{"public_id":"cl_e0902b4de2a1d4978a762497d6e18021","status":"active","superseded_by_public_id":null,"corpus_id":6793687,"text":"CHOP produced 71% complete remissions and 92% overall responses in 204 evaluable patients with advanced non-Hodgkin's lymphoma.","confidence":0.99,"paper":{"corpus_id":6793687,"title":"Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma","url":"https://sah.borca.ai/papers/6793687"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.99,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_33db0d5b7afbdf542c9792fefc3c6bb3","name":"CHOP","description":"A combination chemotherapy regimen containing cyclophosphamide, Adriamycin, vincristine, and prednisone.","types":["chemotherapy regimen"],"url":"https://sah.borca.ai/concepts/co_33db0d5b7afbdf542c9792fefc3c6bb3"},{"public_id":"co_6080da420699c430035fc815b9018508","name":"advanced non-Hodgkin's lymphoma","description":"A pathologically staged advanced form of non-Hodgkin's lymphoma treated with the reported regimens.","types":["disease"],"url":"https://sah.borca.ai/concepts/co_6080da420699c430035fc815b9018508"},{"public_id":"co_920024d341e9de6606bc2e6ad6da3a94","name":"complete remission","description":"A treatment outcome in which no detectable disease remains.","types":["outcome"],"url":"https://sah.borca.ai/concepts/co_920024d341e9de6606bc2e6ad6da3a94"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_e0902b4de2a1d4978a762497d6e18021"}